176 related articles for article (PubMed ID: 2586713)
21. [Cytotoxic effector mechanism and genetic control of non-immunized hybrid resistance to mouse T cell lymphoma transplanted outside and inside the brain].
Yamasaki T; Kikuchi H; Ljunggren HG; Kärre K; Klein G
Neurol Med Chir (Tokyo); 1990; 30(11 Spec No):800-5. PubMed ID: 1709455
[TBL] [Abstract][Full Text] [Related]
22. AK cells were developed from NK cells during in vitro culture of allogeneic or F1 anti-parental stimulation: functional conversion in recognizing H-2 expression of target cells accompanied by phenotypical conversion.
Taniguchi K; Kawano YI; Nomoto K
Immunology; 1988 Aug; 64(4):669-76. PubMed ID: 2971609
[TBL] [Abstract][Full Text] [Related]
23. Absence of major histocompatibility complex class I on neural stem cells does not permit natural killer cell killing and prevents recognition by alloreactive cytotoxic T lymphocytes in vitro.
Mammolenti M; Gajavelli S; Tsoulfas P; Levy R
Stem Cells; 2004; 22(6):1101-10. PubMed ID: 15536199
[TBL] [Abstract][Full Text] [Related]
24. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
Holmes KV; Welsh RM; Haspel MV
J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
[TBL] [Abstract][Full Text] [Related]
25. Sensitivity of simian virus 40-transformed C57BL/6 mouse embryo fibroblasts to lysis by murine natural killer cells.
Fresa KL; Karjalainen HE; Tevethia SS
J Immunol; 1987 Feb; 138(4):1215-20. PubMed ID: 3027174
[TBL] [Abstract][Full Text] [Related]
26. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
Weinhold KJ; Wheelock EF
Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
[TBL] [Abstract][Full Text] [Related]
27. Genetic control of in vitro NK-activity and in vivo resistance to tumors.
Kärre K; Klein GO; Kiessling R; Klein G
Tokai J Exp Clin Med; 1983 Dec; 8(5-6):429-48. PubMed ID: 6681339
[TBL] [Abstract][Full Text] [Related]
28. An oligosaccharide biosynthetic defect in concanavalin A-resistant Chinese hamster ovary (CHO) cells that enhances NK reactivity in vitro and in vivo.
Pohajdak B; Wright JA; Greenberg AJ
J Immunol; 1984 Nov; 133(5):2423-9. PubMed ID: 6481160
[TBL] [Abstract][Full Text] [Related]
29. Surface markers on natural killer cells of the mouse.
Habu S; Hayakawa K; Okumura K; Tada T
Eur J Immunol; 1979 Dec; 9(12):938-42. PubMed ID: 317706
[TBL] [Abstract][Full Text] [Related]
30. Modulation of major histocompatibility complex antigens and inhibition of proliferative activity of YAC lymphoma cells by a natural killer lysis resistance-inducing factor (NK-LRIF).
Saxena RK; Chrest FJ; Adler WH
Nat Immun Cell Growth Regul; 1989; 8(4):197-208. PubMed ID: 2571927
[TBL] [Abstract][Full Text] [Related]
31. Demonstration of natural antibodies in normal rabbit serum with similar specificity pattern as mouse natural killer cells.
Grönberg A; Hansson M; Kiessling R; Andersson B; Kärre K; Roder J
J Natl Cancer Inst; 1980 May; 64(5):1113-9. PubMed ID: 6966004
[TBL] [Abstract][Full Text] [Related]
32. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice.
Gorelik E
Cancer Res; 1987 Feb; 47(3):809-15. PubMed ID: 3802083
[TBL] [Abstract][Full Text] [Related]
33. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
[TBL] [Abstract][Full Text] [Related]
34. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
[TBL] [Abstract][Full Text] [Related]
35. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells.
Johnson PW; Trimble WS; Hozumi N; Roder JC
J Immunol; 1987 Jun; 138(11):3996-4003. PubMed ID: 3495578
[TBL] [Abstract][Full Text] [Related]
36. Mouse brain: an immunologically privileged site for natural resistance against lymphoma cells.
Circolo A; Bianchi R; Nardelli B; Rivosecchi-Merletti P; Bonmassar E
J Immunol; 1982 Feb; 128(2):556-62. PubMed ID: 7054288
[No Abstract] [Full Text] [Related]
37. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
38. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus.
Bukowski JF; Biron CA; Welsh RM
J Immunol; 1983 Aug; 131(2):991-6. PubMed ID: 6190947
[TBL] [Abstract][Full Text] [Related]
39. Protective effect of NK1.1(+) T cells as well as NK cells against intraperitoneal tumors in mice.
Kawamura T; Seki S; Takeda K; Narita J; Ebe Y; Naito M; Hiraide H; Abo T
Cell Immunol; 1999 May; 193(2):219-25. PubMed ID: 10222065
[TBL] [Abstract][Full Text] [Related]
40. IL-10 converts mouse lymphoma cells to a CTL-resistant, NK-sensitive phenotype with low but peptide-inducible MHC class I expression.
Salazar-Onfray F; Petersson M; Franksson L; Matsuda M; Blankenstein T; Kärre K; Kiessling R
J Immunol; 1995 Jun; 154(12):6291-8. PubMed ID: 7759867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
